Profile

Cover photo
MYOS Corporation
16 followers|7,811 views
AboutPostsPhotosYouTube
People
Have them in circles
16 people
Waqas Ahmad's profile photo
World Free From Cancer's profile photo
Value Of Innovation's profile photo
The Life Sciences Report's profile photo
XANOFI's profile photo
Kevin Baker's profile photo
Nuliv Science's profile photo
Alberto Di Miceli's profile photo
JR Associates Medical Reimbursement Consultants's profile photo
Contact Information
Contact info
Phone
(973) 509-0444
Address
45 Horsehill Road, Suite 106 Cedar Knolls, NJ 07927
Story
Tagline
MYOS is dedicated to developing innovative products that improve muscle mass, increase mobility and reduce frailty.
Introduction
MYOS is a BioNutrition and BioTherapeutics company focused on development and commercialization of products that improve muscle health and reduce frailty.

MYOS is the owner of MYO-T12, the first clinically demonstrated natural myostatin inhibitor. Myostatin is a natural regulatory protein, which inhibits muscle growth and recovery. MYO-T12 is manufactured to optimize biological activity, which MYOS believes has the potential to redefine existing standards for muscle health.

Currently we market two Bionutritional products to the general public. Sales of these formulations — Myo-X and MYO-T12 — are being invested in our research and development program and to commercialize other Bionutritional products to treat muscle-related conditions.

We will seek to gain market share for our core branded product, MYO-X, powered by MYO-T12, in the marketplace by:
  • Establishing the safety and clinical benefit of our products through basic and clinical research
  • Expanding distribution of our products by expanding market penetration supported by compelling scientific evidence
  • Expanding distribution globally
  • Formulating and developing new and complementary product lines to capitalize on new treatment opportunities
  • Making strategic product acquisitions and partnerships to promote broader use of our processes and Bionutritional product line.

Stream

 
PRE-ORDER RE MUSCLE HEALTH TODAY! http://www.remusclehealth.com  #rebuild #rejuvenate #results 
1
Add a comment...

MYOS Corporation

Shared publicly  - 
 
Stay tuned for the launch of MYOS Corporations new product line. ‪#‎ComingSoon‬ ‪#‎Fortetropin‬ ‪#‎rebuild‬ ‪#‎rejuvenate‬ ‪#‎results‬ ‪#‎revolutionary‬
1
Add a comment...

MYOS Corporation

Shared publicly  - 
 
MYOS Corporation to Present Mechanism of Action Data at the Experimental Biology Conference
-The Effect of Fortetropin(TM) on Anabolic and Catabolic Signaling in Skeletal Muscle
Click here to see full press release.
http://bit.ly/1EIcoYj
The Effect of Fortetropin(TM) on Anabolic and Catabolic Signaling in Skeletal Muscle. CEDAR KNOLLS, NJ -- (Marketwired) -- 02/23/15 -- MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and ...
1
Add a comment...

MYOS Corporation

Shared publicly  - 
 
MEDIA ALERT
MYOS Corporation: Ticker (NASDAQ) MYOS
www.myoscorp.com
 
Click below to listen to Dr. Robert Hariri’s Interview about MYOS Corporation on Clear Channel "The Trader's Network Show".

https://www.youtube.com/embed/nwSXETGihAI
1
Add a comment...

MYOS Corporation

Shared publicly  - 
 
Chairman Dr. Robert Hariri of MYOS Corporation to Be Interviewed Live on Clear Channel's "The Trader's Network Show" iHeartRadio iHeartMedia Inc.
Live Interview to Air February 14th 2015 Hosted by Michael Yorba, 1:00pm ET/10:00am PT/12:00pm CT
http://bit.ly/19c5TDh
1
Add a comment...

MYOS Corporation

Shared publicly  - 
 
Hafthór Björnsson Thor new world record 2015. http://youtu.be/JpUrXJNcS_8  
1
Add a comment...
Have them in circles
16 people
Waqas Ahmad's profile photo
World Free From Cancer's profile photo
Value Of Innovation's profile photo
The Life Sciences Report's profile photo
XANOFI's profile photo
Kevin Baker's profile photo
Nuliv Science's profile photo
Alberto Di Miceli's profile photo
JR Associates Medical Reimbursement Consultants's profile photo
 
MYOS Announces the Re Muscle Health Series Powered by #Fortetropin. #rebuild #rejuvenate #results
PRE-ORDER @ www.remusclehealth.com
1
Add a comment...

MYOS Corporation

Shared publicly  - 
 
+iHeartRadio  "HealthTechTalk" Show to Feature +MYOS Corporation Ingredient ‪#‎Fortetropin‬ in Exclusive Interview With Company Chairman, Dr.Robert Hariri. 
http://bit.ly/1BOuwks
Dr. Robert Hariri to Be Interviewed by Ben Chodor on March 7, 2015 at 3:00pm ET/12:00pm PT/2:00pm CT. CEDAR KNOLLS, NJ -- (Marketwired) -- 03/06/15 -- MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, ...
1
Add a comment...
 
Justin Bieber didn’t just reveal his chest for the cover of Men’s Health’s April issue. The 21-year-old “Boyfriend” singer also revealed plenty of hidden truths about his life.
1
Add a comment...

MYOS Corporation

Shared publicly  - 
 
Listen to @HaririRobert's interview at 1:00PM EST today on Clear Channel's "The Trader's Network Show" http://www.iheart.com/live/4276/?autoplay=true …@yorbamedia
Dallas-Ft. Worth's News Talk
1
Add a comment...

MYOS Corporation

Shared publicly  - 
 
US egg consumption grows for a fifth consecutive year.http://goo.gl/hTCbkc  @IncredibleEggs
1
Add a comment...

MYOS Corporation

Shared publicly  - 
 
MYOS Corporation Research Selected to Be Presented at International Conference on Molecular and Cellular Biology.
MYOS has developed a novel bioanalytical methodology for proteome mapping using multi-dimensional separations and accurate mass, high resolution mass spectrometry. This methodology has been used to study the early changes that take place in hen egg yolk upon fertilization at the proteomic-level and may also be useful for human proteome studies as well. Fertilized chicken egg yolk is the source of active proteins in ‪#‎Fortetropin‬™, a unique orally administered dietary supplement clinically shown to reduce serum myostatin levels and increase lean body mass and muscle thickness. Recently, MYOS has also demonstrated in preclinical studies that Fortetropin upregulates the mTOR pathway, an important pathway for the synthesis of muscle proteins, and down-regulates the ubiquitin pathway, a pathway involved in muscle protein degradation. MYOS is working to further characterize beneficial proteins, lipids and other bioactive molecules found in Fortetropin.
Please click here to review full release. http://bit.ly/1CgYslg
1
Add a comment...